Europe Point of Care Molecular Diagnostics Market Size, Share & Industry Trends Analysis Report By Product & Service (Assays & Kits, Instruments & Analyzers and Software & Services), By End User, By Technology, By Application, By Country and Growth Forecast, 2023 - 2030

The Europe Point of Care Molecular Diagnostics Market would witness market growth of 9.9% CAGR during the forecast period (2023-2030).

Point-of-care molecular diagnostics tests have sped up the identification of cardiovascular disorders to enhance patient care in various clinical settings, such as residences, outpatient clinics, acute care, and healthcare facilities in rural regions. Physicians need real-time input to improve patient care in sensitive care environments like operating rooms, critical care units, emergency rooms, or cardiac catheterization suites. Healthcare experts are looking for ways to replace reactive medicine in outpatient clinics with preventative approaches that involve wearables, apps, and mobile technology as essential elements.

One of the PoC tests kinds that is expanding the quickest is molecular testing, which detects an infectious agent's genetic material. Many tests are used inside and outside hospitals because they are quick, portable, and affordable. Companies like Cepheid, Alere, and Roche Diagnostics have already made their presence known in this market. Companies are designing assays & molecular diagnostic systems for near patient testing due to the growing interest in establishing molecular diagnostic platforms that can be employed in PoC situations.

4.2% of all TB patients with known HIV also had the virus. For the 17 EU/EEA countries that provided data, the notification rate for TB cases in prisons was 217 new cases and relapses per 100,000 prisoners, or a relative risk of 14.7 compared to the general population in the same countries. A total of 67.6% of the 55 337 TB cases recorded in 2017 with a documented treatment outcome in 2018 were successfully treated, while 6.9% resulted in death. Of the 1182 MDR TB patients registered in 2016 but not treated, 49.9% were successfully treated, while 15.7% died. These elements would fuel the expansion of POC testing throughout Europe.

The Germany market dominated the Europe Point of Care Molecular Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $269.8 million by 2030. The UK market is estimated to grow at a CAGR of 9% during (2023 - 2030). Additionally, The France market would exhibit a CAGR of 10.7% during (2023 - 2030).

Based on Product & Service, the market is segmented into Assays & Kits, Instruments & Analyzers and Software & Services. Based on End User, the market is segmented into Physicians Offices, Hospitals & ICUs, Research Institutes and Others. Based on by Technology, the market is segmented into RT-PCR, Isothermal Nucleic Acid Amplification Technology (INAAT) and Others. Based on Application, the market is segmented into Respiratory Diseases, Hospital-acquired Infections, Sexually Transmitted Diseases, Cancer, Hepatitis, Gastrointestinal Disorders and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Worldwide Point of Care Molecular Diagnostics Market is Projected to reach USD 4.1 Billion by 2030, at a CAGR of 10.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, F. Hoffmann-La Roche Ltd., Qiagen N.V., Danaher Corporation, Bio-Rad Laboratories, Inc., BioMerieux S.A., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., and Nova Biomedical Corporation.

Scope of the Study

Market Segments Covered in the Report:

By Product & Service

• Assays & Kits
• Instruments & Analyzers
• Software & Services Surveillance & Monitoring

By End User

• Physicians Offices
• Hospitals & ICUs
• Research Institutes
• Others

By Technology

• RT-PCR
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Others

By Application

• Respiratory Diseases
• Hospital-acquired Infections
• Sexually Transmitted Diseases
• Cancer
• Hepatitis
• Gastrointestinal Disorders
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• Bayer AG
• F.Hoffmann-La Roche Ltd.
• Qiagen N.V.
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• BioMerieux S.A.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• Nova Biomedical Corporation

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Point of Care Molecular Diagnostics Market, by Product & Service
1.4.2 Europe Point of Care Molecular Diagnostics Market, by End User
1.4.3 Europe Point of Care Molecular Diagnostics Market, by Technology
1.4.4 Europe Point of Care Molecular Diagnostics Market, by Application
1.4.5 Europe Point of Care Molecular Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)

Chapter 4. Europe Point of Care Molecular Diagnostics Market by Product & Service
4.1 Europe Assays & Kits Market by Country
4.2 Europe Instruments & Analyzers Market by Country
4.3 Europe Software & Services Market by Country

Chapter 5. Europe Point of Care Molecular Diagnostics Market by End User
5.1 Europe Physicians Offices Market by Country
5.2 Europe Hospitals & ICUs Market by Country
5.3 Europe Research Institutes Market by Country
5.4 Europe Others Market by Country

Chapter 6. Europe Point of Care Molecular Diagnostics Market by Technology
6.1 Europe RT-PCR Market by Country
6.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe Point of Care Molecular Diagnostics Market by Application
7.1 Europe Respiratory Diseases Market by Country
7.2 Europe Hospital-acquired Infections Market by Country
7.3 Europe Sexually Transmitted Diseases Market by Country
7.4 Europe Cancer Market by Country
7.5 Europe Hepatitis Market by Country
7.6 Europe Gastrointestinal Disorders Market by Country
7.7 Europe Others Market by Country
Chapter 8. Europe Point of Care Molecular Diagnostics Market by Country
8.1 Germany Point of Care Molecular Diagnostics Market
8.1.1 Germany Point of Care Molecular Diagnostics Market by Product & Service
8.1.2 Germany Point of Care Molecular Diagnostics Market by End User
8.1.3 Germany Point of Care Molecular Diagnostics Market by Technology
8.1.4 Germany Point of Care Molecular Diagnostics Market by Application
8.2 UK Point of Care Molecular Diagnostics Market
8.2.1 UK Point of Care Molecular Diagnostics Market by Product & Service
8.2.2 UK Point of Care Molecular Diagnostics Market by End User
8.2.3 UK Point of Care Molecular Diagnostics Market by Technology
8.2.4 UK Point of Care Molecular Diagnostics Market by Application
8.3 France Point of Care Molecular Diagnostics Market
8.3.1 France Point of Care Molecular Diagnostics Market by Product & Service
8.3.2 France Point of Care Molecular Diagnostics Market by End User
8.3.3 France Point of Care Molecular Diagnostics Market by Technology
8.3.4 France Point of Care Molecular Diagnostics Market by Application
8.4 Russia Point of Care Molecular Diagnostics Market
8.4.1 Russia Point of Care Molecular Diagnostics Market by Product & Service
8.4.2 Russia Point of Care Molecular Diagnostics Market by End User
8.4.3 Russia Point of Care Molecular Diagnostics Market by Technology
8.4.4 Russia Point of Care Molecular Diagnostics Market by Application
8.5 Spain Point of Care Molecular Diagnostics Market
8.5.1 Spain Point of Care Molecular Diagnostics Market by Product & Service
8.5.2 Spain Point of Care Molecular Diagnostics Market by End User
8.5.3 Spain Point of Care Molecular Diagnostics Market by Technology
8.5.4 Spain Point of Care Molecular Diagnostics Market by Application
8.6 Italy Point of Care Molecular Diagnostics Market
8.6.1 Italy Point of Care Molecular Diagnostics Market by Product & Service
8.6.2 Italy Point of Care Molecular Diagnostics Market by End User
8.6.3 Italy Point of Care Molecular Diagnostics Market by Technology
8.6.4 Italy Point of Care Molecular Diagnostics Market by Application
8.7 Rest of Europe Point of Care Molecular Diagnostics Market
8.7.1 Rest of Europe Point of Care Molecular Diagnostics Market by Product & Service
8.7.2 Rest of Europe Point of Care Molecular Diagnostics Market by End User
8.7.3 Rest of Europe Point of Care Molecular Diagnostics Market by Technology
8.7.4 Rest of Europe Point of Care Molecular Diagnostics Market by Application

Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Bayer AG
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 F. Hoffmann-La Roche Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 BioMerieux S.A.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Acquisition and Mergers:
9.6 Qiagen N.V.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.8 Bio-Rad laboratories, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Acquisition and Mergers:
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.10. Nova Biomedical Corporation
9.10.1 Company Overview

TABLE 1 Europe Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 2 Europe Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Point of Care Molecular Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Point of Care Molecular Diagnostics Market
TABLE 5 Acquisition and Mergers– Point of Care Molecular Diagnostics Market
TABLE 6 Europe Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 7 Europe Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 8 Europe Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 9 Europe Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 10 Europe Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 11 Europe Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 12 Europe Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 13 Europe Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 14 Europe Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 15 Europe Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 16 Europe Physicians Offices Market by Country, 2019 - 2022, USD Million
TABLE 17 Europe Physicians Offices Market by Country, 2023 - 2030, USD Million
TABLE 18 Europe Hospitals & ICUs Market by Country, 2019 - 2022, USD Million
TABLE 19 Europe Hospitals & ICUs Market by Country, 2023 - 2030, USD Million
TABLE 20 Europe Research Institutes Market by Country, 2019 - 2022, USD Million
TABLE 21 Europe Research Institutes Market by Country, 2023 - 2030, USD Million
TABLE 22 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 23 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 24 Europe Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 25 Europe Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 26 Europe RT-PCR Market by Country, 2019 - 2022, USD Million
TABLE 27 Europe RT-PCR Market by Country, 2023 - 2030, USD Million
TABLE 28 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2019 - 2022, USD Million
TABLE 29 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2023 - 2030, USD Million
TABLE 30 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 31 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 32 Europe Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 33 Europe Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 34 Europe Respiratory Diseases Market by Country, 2019 - 2022, USD Million
TABLE 35 Europe Respiratory Diseases Market by Country, 2023 - 2030, USD Million
TABLE 36 Europe Hospital-acquired Infections Market by Country, 2019 - 2022, USD Million
TABLE 37 Europe Hospital-acquired Infections Market by Country, 2023 - 2030, USD Million
TABLE 38 Europe Sexually Transmitted Diseases Market by Country, 2019 - 2022, USD Million
TABLE 39 Europe Sexually Transmitted Diseases Market by Country, 2023 - 2030, USD Million
TABLE 40 Europe Cancer Market by Country, 2019 - 2022, USD Million
TABLE 41 Europe Cancer Market by Country, 2023 - 2030, USD Million
TABLE 42 Europe Hepatitis Market by Country, 2019 - 2022, USD Million
TABLE 43 Europe Hepatitis Market by Country, 2023 - 2030, USD Million
TABLE 44 Europe Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Million
TABLE 45 Europe Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Million
TABLE 46 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 47 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 48 Europe Point of Care Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
TABLE 49 Europe Point of Care Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
TABLE 50 Germany Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 51 Germany Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 52 Germany Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 53 Germany Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 54 Germany Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 55 Germany Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 56 Germany Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 57 Germany Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 58 Germany Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 59 Germany Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 60 UK Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 61 UK Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 62 UK Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 63 UK Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 64 UK Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 65 UK Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 66 UK Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 67 UK Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 68 UK Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 69 UK Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 70 France Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 71 France Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 72 France Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 73 France Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 74 France Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 75 France Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 76 France Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 77 France Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 78 France Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 79 France Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 80 Russia Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 81 Russia Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 82 Russia Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 83 Russia Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 84 Russia Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 85 Russia Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 86 Russia Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 87 Russia Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 88 Russia Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 89 Russia Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 90 Spain Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 91 Spain Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 92 Spain Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 93 Spain Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 94 Spain Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 95 Spain Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 96 Spain Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 97 Spain Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 98 Spain Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 99 Spain Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 100 Italy Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 101 Italy Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 102 Italy Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 103 Italy Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 104 Italy Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 105 Italy Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 106 Italy Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 107 Italy Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 108 Italy Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 109 Italy Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 110 Rest of Europe Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 111 Rest of Europe Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 112 Rest of Europe Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 113 Rest of Europe Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 114 Rest of Europe Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 115 Rest of Europe Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 116 Rest of Europe Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 117 Rest of Europe Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 118 Rest of Europe Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 119 Rest of Europe Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 120 Key Information – Abbott Laboratories
TABLE 121 Key Information – Bayer AG
TABLE 122 Key Information – Thermo Fisher Scientific, Inc.
TABLE 123 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 124 Key information – BioMerieux S.A.
TABLE 125 Key Information – Qiagen N.V.
TABLE 126 Key Information – Danaher Corporation
TABLE 127 Key Information – Bio-Rad Laboratories, Inc.
TABLE 128 key Information – Agilent Technologies, Inc.
TABLE 129 key information – Nova Biomedical Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Europe Point of Care Molecular Diagnostics Market share by Product & Service, 2022
FIG 5 Europe Point of Care Molecular Diagnostics Market share by Product & Service, 2030
FIG 6 Europe Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2030, USD Million
FIG 7 Europe Point of Care Molecular Diagnostics Market share by End User, 2022
FIG 8 Europe Point of Care Molecular Diagnostics Market share by End User, 2030
FIG 9 Europe Point of Care Molecular Diagnostics Market by End User, 2019 - 2030, USD Million
FIG 10 Europe Point of Care Molecular Diagnostics Market share by Technology, 2022
FIG 11 Europe Point of Care Molecular Diagnostics Market share by Technology, 2030
FIG 12 Europe Point of Care Molecular Diagnostics Market by Technology, 2019 - 2030, USD Million
FIG 13 Europe Point of Care Molecular Diagnostics Market share by Application, 2022
FIG 14 Europe Point of Care Molecular Diagnostics Market share by Application, 2030
FIG 15 Europe Point of Care Molecular Diagnostics Market by Application, 2019 - 2030, USD Million
FIG 16 Europe Point of Care Molecular Diagnostics Market share by Country, 2022
FIG 17 Europe Point of Care Molecular Diagnostics Market share by Country, 2030
FIG 18 Europe Point of Care Molecular Diagnostics Market by Country, 2019 - 2030, USD Million
FIG 19 Swot Analysis: Abbott Laboratories
FIG 20 Swot Analysis: Bayer AG
FIG 21 Swot Analysis: Thermo Fisher Scientific, Inc.
FIG 22 Recent strategies and developments: F. Hoffmann-La Roche Ltd.